Rallybio fails Nasdaq bid price compliance; transfer to Capital Market grants extension to Feb 2026

Rallybio Corp

Nasdaq notified Rallybio on Aug 26, 2025 of transfer to Capital Market; stock continues trading as RLYB.
Company failed to regain $1.00 minimum bid price by Aug 25, 2025 deadline; new compliance date is Feb 23, 2026.
If not compliant by Feb 23, 2026, Nasdaq will issue delisting notice; Rallybio may appeal or pursue reverse stock split.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.